Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FWKUQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,510
Award facts
- Contract value 100% obligated
- $40,509.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,509.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for KEVZARA 200 MG/1.14 ML pen injections on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product is being delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor for federal medical procurement.
This delivery order represents a routine pharmaceutical supply transaction under DLA's comprehensive global pharmaceutical support vehicle that enables AmerisourceBergen to supply specialty medications, brand-name and generic drugs, and other medical commodities to support military healthcare programs. KEVZARA (sarilumab) is a biologic treatment commonly used for rheumatoid arthritis and severe COVID-19, reflecting the breadth of therapeutic domains covered under the prime contract. As a child contract under the larger SPE2DX IDC, this award demonstrates AmerisourceBergen's critical role in the Defense Health Agency's medical supply chain and its capacity to fulfill federal healthcare requirements through both small-value and substantial pharmaceutical orders.
Quick answers
Who was awarded contract SPE2DB25FWKUQ?
SPE2DB25FWKUQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FWKUQ worth?
The government has obligated $40,510 on SPE2DB25FWKUQ.
Is contract SPE2DB25FWKUQ an order under another contract?
Yes. SPE2DB25FWKUQ is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKUQ competed?
The extent of competition for SPE2DB25FWKUQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award